Abeona Therapeutics Statistics
NASDAQ: ABEOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.42-0.03 (-1.22%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Abeona Therapeutics by the numbers
Abeona Therapeutics has a market capitalization of $165.3 million based on 68.31M shares outstanding. With trailing EPS of $-1.16, Abeona Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 44.8% below its 50-day average and 54.6% below its 200-day average.
Average daily trading volume is 1.66M shares, or about $4.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ABEO valuation vs. peer median
| Metric | ABEO | Peer median | Difference |
|---|---|---|---|
| Market cap | $165.31M | $171.38M | -4% |
| Avg. volume | 1.66M | 179.70K | +822% |
Peer median across 8 companies: KRRO, TRDA, EMIS, SIGA, VOGX, NATR, ORMP, ADCT.
Valuation
- Market cap
- $165.31M
- Price / sales (latest FY)
- 28.40
- EPS (TTM)
- $-1.16
- Shares outstanding
- 68.31M
Price and trading
- Previous close
- 2.45
- Open
- 2.43
- Day range
- 2.40 – 2.57
- 52-week range
- 2.09 – 7.65
- 52-week change
- -45.98%
- Beta
- —
- Volume
- 4.72M
- Average volume
- 1.66M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 165.31M
- Forward Pe
- -5.02
- Eps
- -1.16
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.65
- Week52 Low
- 2.09
- Avg Volume
- 1.66M
- Shares Outstanding
- 68.31M
- Ma50
- 4.38
- Ma200
- 5.33
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -68.37%
- Pct From52w Low
- 15.79%